Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02658214
What this trial is testing

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaCarcinoma, Squamous Cell of Head and NeckStomach Neoplasms+7 more
AstraZeneca 32
Testing effectiveness (Phase 2)Ended earlyNCT04046328
What this trial is testing

Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome

Who this might be right for
Short Bowel Syndrome
Pharmascience Inc. 13
Early research (Phase 1)Study completedNCT04931147
What this trial is testing

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Who this might be right for
FibrosisInflammationIdiopathic Pulmonary Fibrosis+3 more
Redx Pharma Ltd 90
Large-scale testing (Phase 3)Active Not RecruitingNCT06910358
What this trial is testing

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)
Disc Medicine, Inc 183
Early research (Phase 1)Study completedNCT01897038
What this trial is testing

A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 9
Early research (Phase 1)Study completedNCT01984658
What this trial is testing

A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of ALECSAT to Pancreas Cancer Patients

Who this might be right for
Pancreatic Cancer
CytoVac A/S 10
Early research (Phase 1)Study completedNCT00844064
What this trial is testing

Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2

Who this might be right for
Pancreatic NeoplasmsMelanomaColorectal Neoplasms
Isarna Therapeutics GmbH 62
Testing effectiveness (Phase 2)Ended earlyNCT02787304
What this trial is testing

Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis
Mirum Pharmaceuticals, Inc. 197
Testing effectiveness (Phase 2)Looking for participantsNCT03093116
What this trial is testing

Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Turning Point Therapeutics, Inc. 500
Early research (Phase 1)Looking for participantsNCT07646106
What this trial is testing

THE-0504 in Patients With Solid Tumors

Who this might be right for
Small Cell Lung Cancer (SCLC)Colorectal Carcinoma (CRC)Gastric Cancer (GC)+2 more
Thena Biotech S.r.l. 30
Early research (Phase 1)Looking for participantsNCT06769425
What this trial is testing

HS-10502 Combination Treatment in Patients With Advanced Solid Tumors

Who this might be right for
Recurrent Ovarian CancerHER2-negativeAdvanced Breast Cancer+3 more
Jiangsu Hansoh Pharmaceutical Co., Ltd. 157
Not applicableStudy completedNCT07176325
What this trial is testing

Gastrointestinal and Fluid Retention Symptoms Associated With Creatine Monohydrate With and Without Loading Dose Over 28 Days of Supplementation

Who this might be right for
Side Effects of Creatine Monohydrate Dosing
Vireo Systems, Inc. 24
Large-scale testing (Phase 3)Study completedNCT02673749
What this trial is testing

Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance

Who this might be right for
Lactose Intolerance
Ritter Pharmaceuticals, Inc. 377
Testing effectiveness (Phase 2)Study completedNCT04118114
What this trial is testing

Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors

Who this might be right for
Gastric CancerHepatocellular CarcinomaAdvanced Solid Tumor
National Cancer Centre, Singapore 14
Not applicableStudy completedNCT00546663
What this trial is testing

Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
CF Therapeutics Development Network Coordinating Center 19
Early research (Phase 1)UnknownNCT04386915
What this trial is testing

Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets

Who this might be right for
Hepatitis B
Fujian Cosunter Pharmaceutical Co. Ltd 104
Testing effectiveness (Phase 2)UnknownNCT00044135
What this trial is testing

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Who this might be right for
Hepatitis B
Triangle Pharmaceuticals 30
Testing effectiveness (Phase 2)Looking for participantsNCT05462236
What this trial is testing

MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
AUM Biosciences Pte Ltd 120
Not applicableLooking for participantsNCT06690632
What this trial is testing

WAter Preparation in Crohn's Disease's Imagery

Who this might be right for
Crohn Disease (CD)
University Hospital, Toulouse 194
Early research (Phase 1)Looking for participantsNCT06680232
What this trial is testing

Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B

Who this might be right for
HEPATITIS B CHRONIC
Precision BioSciences, Inc. 45
Next Page